Inhibition of [3H]batrachotoxinin A-20α-benzoate binding to sodium channels and sodium channel function by endocannabinoids

Neurochemistry International

Volumn 52, Issue 3, 2008, Pages 438-446

  Duan, Yin ^a   Zheng, Jian ^b   Nicholson, Russell A ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

3H batrachotoxinin binding; Endocannabinoids; l Glutamate and GABA release; Membrane potential; Mouse brain; Sodium channel

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 4 AMINOBUTYRIC ACID; BATRACHOTOXININ A 20ALPHA BENZOATE; BENZYLSULFONYL FLUORIDE; ENDOCANNABINOID; HYDROGEN; SODIUM CHANNEL; VERATRIDINE; VOLTAGE GATED SODIUM CHANNEL; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ARACHIDONIC ACID DERIVATIVE; BATRACHOTOXIN; BATRACHOTOXININ A 20 ALPHA BENZOATE; BATRACHOTOXININ A 20-ALPHA-BENZOATE; CANNABINOID 1 RECEPTOR; TRITIUM;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN; CELL MEMBRANE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DEPOLARIZATION; MEMBRANE POTENTIAL; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; ALLOSTERISM; ANIMAL; BINDING COMPETITION; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; PHARMACOKINETICS; RADIOASSAY; SECRETION; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

ALLOSTERIC REGULATION; ANIMALS; ARACHIDONIC ACIDS; BATRACHOTOXINS; BINDING SITES; BINDING, COMPETITIVE; BRAIN; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; GLYCERIDES; MICE; MOLECULAR STRUCTURE; NEUROTRANSMITTER AGENTS; PHARMACOKINETICS; PRESYNAPTIC TERMINALS; RADIOLIGAND ASSAY; RECEPTOR, CANNABINOID, CB1; SODIUM CHANNELS; SYNAPTIC TRANSMISSION; SYNAPTOSOMES; TRITIUM;

EID: 38049053476     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.08.004     Document Type: Article

References (38)

1. Bisogno T., Melck D., Bobrov M.Y., Gretskaya N.M., Bezuglov V.V., De Petrocellis L., and Di Marzo V. N-Acyl-dopamines: novel synthetic CB1 cannabinoid receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem. J. 351 (2000) 817-824
2. 3H]batrachotoxinin A-20-benzoate to a receptor site associated with sodium channels in synaptic nerve ending particles. J. Biol. Chem. 256 (1981) 8922-8927
3. Deadwyler S.A., Hampson R.E., Bennett B.A., Edwards T.A., Mu J., Pacheco M.A., Ward S.J., and Childers S.R. Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels 1 (1993) 121-134
4. Deecher D.C., Payne D.M., and Soderlund D.M. Inhibition of batrachotoxinin A-20-α-benzoate binding to mouse brain sodium channels by the dihydropyrazole insecticide RH-3421. Pestic. Biochem. Physiol. 41 (1991) 265-273
5. Devane W.A., Dysarz III F.A., Johnson M.R., Melvin L.S., and Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34 (1988) 605-613
6. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
7. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.-C., and Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372 (1994) 686-691
8. Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.J., Zimmer A.M., Zimmwer A., and Martin B.R. Levels metabolism and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice: evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 75 (2000) 2434-2444
9. Dunkley P.R., Jarvie P.E., Heath G.W., Kidd G.J., and Rostas J.A.P. A rapid method for isolation of synaptosomes on percoll gradients. Brain Res. 372 (1986) 115-129
10. Evans R.M., Scott R.H., and Ross R.A. Multiple actions of anandamide on neonatal rat cultured sensory neurones. Br. J. Pharmacol. 141 (2004) 1223-1233
11. Fezza F., Bisogno T., Minassi, Appendino G., Mechoulam R., and Di Marzo V. Noladin ether, a putative novel endocannabinoid:inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Lett. 513 (2002) 294-298
12. Fride E., and Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist anandamide, a brain constituent. Eur. J. Pharmacol. 231 (1993) 313-314
13. Goparaju S.K., Ueda N., Yamaguchi H., and Yamamoto S. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett. 422 (1998) 69-73
14. 1 receptor. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3662-3665
15. Harris R.A., and Allen A.M. Functional coupling of γ-aminobutyric acid receptors to chloride channels in brain membranes. Science 228 (1985) 1108-1110
16. Huang S.M., Bisogno T., Petros T.J., Chang S.Y., Zavitsanos P.A., Zipkin R.E., Sivakumar R., Coop A., Maeda D.Y., De Petrocellis L., Burstein S., Di Marzo V., and Walker J.M. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem. 276 (2001) 42639-42644
17. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Petros T.J., Krey J.F., Chu C.J., Miller J.D., Davies S.N., Geppetti P., Walker M.J., and Di Marzo V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8400-8405
18. Kilpatrick I.C. Rapid, automated HPLC analysis of neuroactive and other amino acids in microdissected brain regions and brain slice superfusates using fluorimetric detection. In: Greenstein B. (Ed). Neuroendocrine Research Methods vol. 2 (1991), Harwood Academic Publishers, Chur, Switzerland 555-578
19. + currents in rat dorsal root ganglion neurons. Brain Res. 1062 (2005) 39-47
20. Kreitzer A.C., and Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29 (2001) 717-727
21. Leach M.J., Marden C.M., and Miller A.A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug II. Neurochemical studies on the mechanism of action. Epilepsia 27 (1986) 490-497
22. Mackie K., and Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3825-3829
23. Mackie K., Lai Y., Westenbroek R., and Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in ATT20 cells transfected with rat brain cannabinoid receptors. J. Neurosci. 5 (1995) 6552-6561
24. Mandala M., Serck-Hanssen G., Martino G., and Helle K.B. The fluorescent cationic dye rhodamine 6G as a probe for membrane potential in bovine aortic endothelial cells. Analyt. Biochem. 274 (1999) 1-6
25. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Barg J., and Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50 (1995) 83-89
26. Nicholson R.A., Liao C., Zheng J., David L.S., Coyne L., Errington A.C., Singh G., and Lees G. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res. 978 (2003) 194-204
27. Ohno-Shosaku T., Maejima T., and Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized presynaptic neurons to presynaptic terminals. Neuron 29 (2001) 729-738
28. + channels by membrane lipids. Science 304 (2004) 265-270
29. Peterson G.L. A simplification of the method of Lowry et al. which is more generally applicable. Analyt. Biochem. 83 (1977) 346-356
30. 3H]batrachotoxinin A 20-α-benzoate to sodium channels by local anesthetics. Mol. Pharmacol. 25 (1983) 219-227
31. Rando T.A. Rapid and slow gating of veratridine-modified sodium channels in frog myelinated nerve. J. Gen. Physiol. 93 (1989) 43-65
32. 3H]-batrachotoxinin-A 20-α-benzoate binding to voltage-dependent sodium channels in rat cortical synaptosomes. Br. J. Pharmacol. 119 (1996) 1489-1504
33. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., and Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215 (1995) 89-97
34. Twichell W., Brown S., and Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured hippocampal neurons. J. Neurophysiol. 78 (1997) 43-50
35. A receptors and voltage-gated sodium channels in vitro: a putative endogenous ligand for depressant drug sites in CNS. Br. J. Pharmacol. 22 (2000) 627-635
36. 3H]batrachotoxinin A 20-α-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol. Pharmacol. 22 (1982) 627-635
37. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001) 588-592
38. Wilson R.I., and Nicoll R.A. Endocannabinoid signalling in the brain. Science 296 (2002) 678-682